Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS (NCT05646394)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this registry is to gather more information on the efficacy and safety of various antithrombotic regimens. The registry collects data on patients with antiphospholipid syndrome and an arterial event within the past 12 months, on treatment with either A) a VKA with therapeutic range, INR 2.0-3.0 plus low-dose aspirin (75-100 mg daily), B) a VKA alone with therapeutic range, INR 2.0-3.0, C) a VKA with therapeutic range, INR 3.0-4.0, or D) with a dual antiplatelet regimen. The follow-up is 2 years.
Who can join: Review the eligibility criteria below.
Location: Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires — Buenos Aires, Buenos Aires F.D.
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires — Buenos Aires, Buenos Aires F.D.
- Clinica Universitaria Reina Fabiola — Córdoba,
- McMaster University — Hamilton, Ontario
📞 Contact the Study Coordinator
Phone: (905) 527-0271
Email: schulms@mcmaster.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Antiphospholipid Syndrome
- Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome — Durham, North Carolina
- Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study — Sacramento, California
Explore by condition: All Antiphospholipid Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.